Patents Assigned to GE Healthcare AS
-
Patent number: 9327212Abstract: A method for preparing a liquid flow having pre-defined characteristics by mixing liquid flows of at least two different component stock solutions with each other comprises the steps of determining a selected property value for one or more of the stock solutions by sensing, in a flow of each stock solution separately, at least one characteristic related to the property value for the stock solution, and based on the determined property value or values, mixing the stock solution flows in mixing ratios giving the desired mixed liquid flow. A system for carrying out the method comprises sensor means and a control unit, wherein the control unit is arranged to evaluate the characteristics sensed by the sensor means and provide relative ratios of stock solutions required to obtain a mixed liquid flow having the pre-defined characteristics.Type: GrantFiled: September 23, 2010Date of Patent: May 3, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Torbjorn Blank, Enrique Carredano, Karl Ekstrom, Jan-Erik Lynga, Roger Nordberg, Mike Peters, Gustav Rodrigo, Henrik Sandegren, Lisa Stack
-
Patent number: 9329112Abstract: A container holding, and a method of storing, freeze-dried biological samples. The container includes a chamber having an upper portion and a lower portion. The chamber includes a wall, and the lower portion of the chamber is fluidly connected to the upper portion of the chamber such that, when liquid is received at the upper portion, the received liquid can pass to and accumulate in the lower portion. Further, the freeze-dried material is located in the lower portion, and the container includes a physical structure in the form of a stop protruding inwards from the wall, the physical structure being for inhibiting the freeze-dried material from moving from the lower portion of the chamber to the upper portion of the chamber.Type: GrantFiled: January 25, 2012Date of Patent: May 3, 2016Assignee: GE HEALTHCARE UK LIMITEDInventors: Michael John Smith, Stevan Paul Tortorella
-
Patent number: 9322772Abstract: Disclosed is an apparatus for measuring the absorbance of a substance in a solution, comprising: i) a sample cell (30) of known path length (b) for containing said solution (S), said cell being transparent to light of a predefined wavelength spectrum; ii) plural LED's each being independently operable by means of a controller (25) each for emitting light, within said predefined wavelength spectrum, along a light path; iii) a band pass filter (22) in the light path; iv) a beam splitter (24) for dividing light from said source propagating along the path into a first portion and a second portion, said first portion being directable by the beam splitter toward a reference detector (42) and said second portion being directable into the cell (30); v) a reference detector (42) for detecting the intensity of said first portion of light directed by said beam splitter; and vi) a sample detector (40) for detecting the intensity of the second portion propagating from the cell; the apparatus allowing a sample in the cellType: GrantFiled: May 30, 2013Date of Patent: April 26, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Hanno Ehring, Fredrik Lars Jarhede, Erik Ostlund
-
Patent number: 9316636Abstract: A method of determining kinetic parameters for a reversible molecular interaction between a ligand immobilized to a solid support surface and a binding partner to the ligand in solution, comprises sequentially, without intermediate regeneration or renewal of the immobilized ligand, flowing a plurality of fluid volumes containing different known concentrations of the binding partner over the solid support surface, monitoring the momentary amount of binding partner bound to the solid support surface related to time and solution concentration of binding partner and collecting the binding data, and determining the kinetic parameters by globally fitting a predetermined kinetic model for the interaction between the binding partner and the immobilized ligand to the collected binding data, which model allows for mass transport limitation at the solid support surface.Type: GrantFiled: October 25, 2012Date of Patent: April 19, 2016Assignee: GE HEALTHCARE BIO-SCIENCES ABInventors: Robert Karlsson, Karl Andersson, Christina Wass
-
Patent number: 9314541Abstract: The present invention provides a method useful in the diagnosis and monitoring of cancer wherein there is an abnormal expression of PBR. The method of the invention is particularly useful in evaluating the severity of the cancer, e.g. PBR expression correlates with cell proliferation rates, metastatic potential, tumor aggressiveness, malignancy progression. The method of the invention can therefore be applied in the determination of likely disease progression and in making an associated prognosis. Furthermore, the method of the invention can find use in determining the likely success of certain therapeutic approaches, or in the evaluation of the efficacy of certain proposed new treatments.Type: GrantFiled: September 29, 2011Date of Patent: April 19, 2016Assignee: GE Healthcare LimitedInventor: Paul Alexander Jones
-
Patent number: 9316624Abstract: Disclosed herein is a chromatography system wherein a sensor, for example, a UV sensor, is tied to a continuously variable load pump in a feedback control loop, with an option to divert the feed stream back to the load vessel or reservoir or onto a second chromatography column, the disclosed chromatography system allowing a true feedback control across variable load rates, thereby adjusting chromatographic operating parameters, for example, variable load rates, to process conditions, while maximizing throughput.Type: GrantFiled: October 20, 2011Date of Patent: April 19, 2016Assignee: GE HEALTHCARE BIO-SCIENCES CORP.Inventor: Geoffrey L. Hodge
-
Patent number: 9308477Abstract: Embodiments of the invention relate to a syringeless filter device compressor for compressing one or more syringeless filter devices. Such syringeless filter devices are typically compressed entirely by hand; however, this may be uncomfortable and/or dangerous for the operator. In embodiments of the present invention, there is provided an apparatus comprising a holder for holding a plurality of syringeless filter devices in a two-dimensional array, and a compressor device. The compressor includes a pusher which can be moved by an actuator to compress the filtration devices held in the two-dimensional array. These features enable a compact compressor device for compressing syringeless filter devices, without the operator being in contact with the syringeless filter device during the compression process.Type: GrantFiled: June 26, 2012Date of Patent: April 12, 2016Assignee: GE HEALTHCARE UK LIMITEDInventors: David Gwyn Treharne, Stevan Paul Tortorella
-
Patent number: 9302202Abstract: A chromatography column having a longitudinal axis and comprising a column wall with a first end and a second end, a first end plate assembly removably connectable to said first end of the column wall, a second end plate assembly removably connectable to said second end of the column wall, wherein said first end plate assembly, said column wall and said second end plate assembly are arranged along the longitudinal axis of the column wherein the column wall, and/or first end plate assembly and/or second end plate assembly is/are rotatable about an axis of rotation wherein said axis of rotation is parallel to the longitudinal axis of said column and positioned outside the column.Type: GrantFiled: June 4, 2014Date of Patent: April 5, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Per Lofving, Mats Olsson, Sven Wounder, Jerker Persson
-
Patent number: 9296791Abstract: The present invention relates to an immunoglobulin-binding protein, wherein at least one asparagine residue has been mutated to an amino acid other than glutamine or aspartic acid, which mutation confers an increased chemical stability at pH-values of up to about 13-14 compared to the parental molecule. The protein can for example be derived from a protein capable of binding to other regions of the immunoglobulin molecule than the complementarity determining regions (CDR), such as protein A, and preferably the B-domain of Staphylococcal protein A. The invention also relates to a matrix for affinity separation, which comprises an immunoglobulin-binding protein as ligand coupled to a solid support, in which protein ligand at least one asparagine residue has been mutated to an amino acid other than glutamine.Type: GrantFiled: January 14, 2013Date of Patent: March 29, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Sophia Hober, Hans J. Johansson
-
Patent number: 9290549Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates to a process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.Type: GrantFiled: January 27, 2014Date of Patent: March 22, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
-
Patent number: 9290372Abstract: A fluid distributor for uniformly distributing flow of a feed onto a chromatography column in a cost-effective way defines a distribution channel of generally conical shape between a solid back plate and a packed bed in the column, wherein the fluid distributor comprises at least two circular and/or annular fluid-permeable porous disks essentially filling the volume of the distribution channel.Type: GrantFiled: June 14, 2011Date of Patent: March 22, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Peter Bellqvist, Klaus Gebauer
-
Patent number: 9284554Abstract: The present disclosure provides a non-naturally occurring miRNA having a stem-loop structure comprising a scaffold derived from a first endogenous miRNA (e.g., miR-196a-2 or miR-204), a mature strand derived from a second endogenous miRNA, and a star strand sequence that is at least partially complementary to the mature strand sequence. The present disclosure also provides a non-naturally occurring miRNA having a stem-loop structure comprising a scaffold derived from an endogenous miRNA (e.g., miR-196a-2 or miR-204), a mature strand designed to be at least partially complementary to a target RNA, and a star strand sequence that is at least partially complementary to the mature strand sequence. The methods and compositions of the disclosure may be used to mediate gene silencing via the RNAi pathway.Type: GrantFiled: July 30, 2014Date of Patent: March 15, 2016Assignee: GE Healthcare Dharmacon, Inc.Inventors: Melissa Kelley, Amanda Birmingham, Jon Karpilow, Anastasia Khvorova, Kevin Sullivan
-
Patent number: 9284552Abstract: The present disclosure provides a method of modifying cells in order to enhance lentiviral titers, cell lines that are modified and modifying reagents. By mediating individual genes and combination thereof, lentiviral titers may be increased.Type: GrantFiled: April 2, 2013Date of Patent: March 15, 2016Assignee: GE Healthcare Dharmacon, Inc.Inventors: Katie Jansen Spayd, Jon Karpilow, John K. Wakefield
-
Patent number: 9278297Abstract: The present invention relates to a method for running ion exchange chromatography on a media comprising shell beads having an inner porous core and an outer shell, wherein the inner core is provided with ligands whose charge changes with pH and the shell is provided with charged ion exchange ligands, the method comprising the following steps: a) adsorbing sample molecules on the shell ligands at a first pH; b) causing a discharge of the inner core ligands at a second pH by addition of a buffer substance that is able to increase its charge having the same sign/type as that of the core ligands, which at the same time causes release of ions from the inner core ligands and thereby an increase in ionic strength that displaces the sample molecules from the shell ligands i.e. causes an elution.Type: GrantFiled: June 28, 2011Date of Patent: March 8, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Jan Bergstrom, Bo-Lennart Johansson
-
Patent number: 9279789Abstract: A chromatography column distribution system includes a set of first bed support ribs extending radially from an inner, first radial position near the centre of the plate to an outer radial position nearer to the periphery of the plate and at least one set of intermediate bed support ribs starting at an intermediate radial position and extending to an outer radial position nearer to the periphery of the plate. Channels are formed between adjacent bed support ribs. The desired local effective channel height varies in accordance with a predetermined formula from the first radial position to the outer radial position. The transverse cross-sectional areas of the ribs or the channels are adapted such that the actual local effective channel height is within 15% of the desired local effective channel height over portions of the distribution system situated between the first radial position and the outer radial position.Type: GrantFiled: February 18, 2015Date of Patent: March 8, 2016Assignee: GE Healthcare Bio-Sciences ABInventor: Klaus Gebauer
-
Patent number: 9278916Abstract: The invention relates to a process for preparation of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabeled amino acids for use in in vivo imaging procedures such as positron emission tomography (PET). Particularly, the invention relates to a process for preparation of a precursor of the [18F]-1-amino-3-fluorocyclobutanecarboxylic acid ([18F] FACBC) PET agent and particularly to the work-up process of this precursor removing generated salts from the intermediate composition.Type: GrantFiled: November 28, 2011Date of Patent: March 8, 2016Assignee: GE Healthcare LimitedInventors: Tom Christian Berg, Anne Nilsen
-
Patent number: 9278296Abstract: The present invention relates to methods for securing a distributor plate to a backing plate of a chromatography column without the need for releasable fixing means as screws or bolts. The invention also relates to chromatographic columns utilizing such methods. The method employs a negative pressure or vacuum that is generated internally within the column to affix the distributor to the backing plate.Type: GrantFiled: November 28, 2011Date of Patent: March 8, 2016Assignee: GE Healthcare Bio-Sciences ABInventors: Manoj Kumar Ramakrishna, Shashikanth Agnihotry
-
Publication number: 20160060617Abstract: The present invention relates to a method for storage and subsequent lysis of a sample in which the sample is immobilized on a solid support. The solid matrix is embedded with a low concentration of both a chaotropic salt and a surfactant which act synergistically to efficiently store and lyse a biological sample.Type: ApplicationFiled: September 2, 2015Publication date: March 3, 2016Applicant: GE HEALTHCARE UK LIMITEDInventors: Hugh O'MALLEY, Barry JOHNSON
-
Patent number: 9272056Abstract: The invention relates to a dynamic nuclear polarisation method for producing hyperpolarised carboxylates of organic amines and amino compounds and compositions for use in that method. The DNP agent preferably is a stable oxygen-based, sulphur-based or carbon-based trityl radical. Optionally a paramagnetic metal ion is present.Type: GrantFiled: December 15, 2006Date of Patent: March 1, 2016Assignee: GE Healthcare ASInventors: Mikkel Thaning, Karl Andreas Gram
-
Patent number: 9272251Abstract: The invention relates to an impeller for use in a bioreactor for growing adherent mammalian cells and/or a cell separator for adherent mammalian cells. The impeller of the invention is designed to efficiently and rapidly lift a bed of settled cells and microcarrier beads at low rotational speeds. Cell growth and concomitant yield is therefore improved by maintaining the culture in an environment of low shear force.Type: GrantFiled: April 23, 2010Date of Patent: March 1, 2016Assignee: GE HEALTHCARE UK LIMITEDInventors: Christopher Jones, Philip John Meyler, Rhys Evans